PAM
SCMP

Princeton Alpha Management’s Sucampo Pharmaceuticals, Inc. SCMP Stock Holding History

Princeton Alpha Management’s Portfolio SCMP Stock Details SCMP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-12,616
Closed -$138K – 1043
2016
Q2 		$138K Buy
+12,616
New +$141K 0.02% 713

Other funds holding SCMP

LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
KAM
Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
TA
Teachers Advisors New York $81.7B AUM 13.62% 1-Year Est. Return

Princeton Alpha Management's SCMP Position: Q3 2016 in Review

Princeton Alpha Management sold out of Sucampo Pharmaceuticals, Inc. (SCMP) in Q3 2016, closing a stake of 12,616 shares — an estimated $138K sold.

Princeton Alpha Management first reported a position in SCMP in Q2 2016 and held it in 1 quarter. The position peaked at $138K in Q2 2016. 119 funds tracked by Wall St. Rank hold SCMP as of Q3 2016.

  • Princeton Alpha Management reported no remaining Sucampo Pharmaceuticals, Inc. position as of Q3 2016 after selling out during the quarter.
  • Princeton Alpha Management sold 12,616 Sucampo Pharmaceuticals, Inc. shares in Q3 2016, an estimated $138K.
  • Princeton Alpha Management first reported a position in Sucampo Pharmaceuticals, Inc. in Q2 2016 and held it in 1 quarter.
  • Princeton Alpha Management's Sucampo Pharmaceuticals, Inc. position peaked at $138K in Q2 2016.
  • 119 funds tracked by Wall St. Rank held Sucampo Pharmaceuticals, Inc. as of Q3 2016.

Based on Princeton Alpha Management's 13F filing for Q3 2016, filed 10 Nov 2016.